MedTrace Logo

Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection

NCT04792710 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2021-03-11

No results posted yet for this study

Summary

Randomised controlled trial to investigate the efficacy of adding metronidazole pre-operatively to kefazolin in reducing postpartum infection

Conditions

  • Prevention of Postpartum Sepsis

Interventions

DRUG

Metronidazole

Metronidazole 500 mg intravenous stat dose prior to skin incision

Sponsors & Collaborators

  • University of Pretoria

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-03-31
Completion
2022-06-30

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792710 on ClinicalTrials.gov